What is the maximum recommended daily dose of nifedipine (including immediate‑release and extended‑release formulations)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum Dose for Nifedipine

The maximum recommended daily dose of nifedipine is 180 mg for extended-release formulations and 90 mg for immediate-release formulations, though most clinical guidelines reference upper limits of 120-180 mg daily for slow-release preparations. 1, 2, 3, 2, 1

Formulation-Specific Maximum Doses

Extended-Release/Slow-Release Nifedipine

  • Maximum: 180 mg daily orally 1, 2, 3, 2, 1
  • The ACC/AHA guidelines consistently cite this as the upper limit across multiple iterations (2011,2012,2013)
  • Clinical trial data supports doses up to 180 mg daily in the GITS (gastrointestinal therapeutic system) formulation 4

Immediate-Release Nifedipine

  • Maximum: 90 mg daily orally 1, 2, 3, 2, 1
  • However, immediate-release nifedipine is not recommended for routine use in acute coronary syndromes or hypertension due to precipitous blood pressure drops and reflex tachycardia
  • Should only be used with concomitant beta-blockade if used at all 1, 2, 5, 3, 2, 1

Special Population Considerations

Pediatric Populations

Maximum: 3 mg/kg/day up to 120 mg/day for extended-release formulations 6

  • This pediatric guideline from the Expert Panel on Cardiovascular Health provides specific weight-based dosing
  • Children weighing less than 25 kg should not receive single doses greater than 15 mg

Pregnancy

Maximum: Not explicitly defined, but typical range 30-180 mg daily 7

  • Extended-release nifedipine is a preferred first-line agent for chronic hypertension in pregnancy
  • Immediate-release nifedipine can be used for acute severe hypertension (≥160/110 mmHg) in pregnancy 7
  • Recent trial data suggests 30 mg BID dosing may reduce need for emergent antihypertensive treatment compared to 60 mg daily 8

Pulmonary Arterial Hypertension

Maximum: Up to 240 mg daily for diltiazem; 120-240 mg for nifedipine 9

  • The ESC/ERS guidelines note that relatively high doses are required for efficacy in idiopathic PAH
  • Doses should be titrated cautiously starting from 30 mg slow-release twice daily, with limiting factors being systemic hypotension and peripheral edema

Practical Dosing Algorithm

Starting dose: 30 mg once daily (extended-release)

Titration strategy:

  1. Increase by 30 mg increments every 7-14 days based on blood pressure response
  2. Most patients achieve control on 30-60 mg daily 4
  3. If inadequate response at 90 mg daily, consider adding another antihypertensive class rather than further increasing nifedipine
  4. Maximum effective dose rarely exceeds 120 mg daily in clinical practice

Dose-limiting factors:

  • Systemic hypotension
  • Peripheral edema (dose-related: 18% at 30 mg, 29% at 90 mg daily) 10
  • Headache and flushing
  • Reflex tachycardia (particularly with immediate-release)

Critical Safety Considerations

Avoid immediate-release nifedipine without beta-blocker coverage due to:

  • Precipitous blood pressure reduction
  • Reflex sympathetic activation causing tachycardia
  • Potential worsening of myocardial ischemia 1, 2, 5, 3, 2, 1

Three 30 mg tablets are NOT interchangeable with one 90 mg tablet due to substantially higher peak concentrations (29% higher Cmax), which increases adverse effect risk 10

Food effects: High-fat meals increase peak nifedipine concentration by approximately 60%, though total drug exposure (AUC) remains unchanged 10

Grapefruit juice: Avoid completely—causes up to 2-fold increase in drug exposure through CYP3A4 inhibition 10

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.